Biotest
Sebastian Lülf has extensive experience working in scientific roles at various research institutions and companies. Sebastian has a background in biochemistry and biology, with a Doctor of Philosophy degree in Biochemistry from Ruhr University Bochum. Throughout their career, Sebastian has utilized a variety of molecular biology methods and advanced techniques such as crystallography, SDS-PAGE, and fluorescence microscopy analysis. Sebastian has focused on topics such as protein purification, antibody expression, and the inhibition of HIV-1 Nef intracellularly. Currently, Sebastian holds the position of Scientific Manager (Pathogen Safety) at Biotest AG.
This person is not in any teams
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.